Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 25.44 USD -3.31% Market Closed
Market Cap: 1.2B USD

Intrinsic Value

The intrinsic value of one AMPH stock under the Base Case scenario is 40.77 USD. Compared to the current market price of 25.44 USD, Amphastar Pharmaceuticals Inc is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMPH Intrinsic Value
40.77 USD
Undervaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Amphastar Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about AMPH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AMPH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Amphastar Pharmaceuticals Inc.

Explain Valuation
Compare AMPH to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AMPH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amphastar Pharmaceuticals Inc

Current Assets 639.5m
Cash & Short-Term Investments 276.2m
Receivables 148.9m
Other Current Assets 214.4m
Non-Current Assets 1B
PP&E 353.5m
Intangibles 572.2m
Other Non-Current Assets 101m
Current Liabilities 205.2m
Accounts Payable 40.5m
Accrued Liabilities 158.1m
Other Current Liabilities 6.6m
Non-Current Liabilities 684.2m
Long-Term Debt 608.6m
Other Non-Current Liabilities 75.7m
Efficiency

Free Cash Flow Analysis
Amphastar Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Amphastar Pharmaceuticals Inc

Revenue
723.3m USD
Cost of Revenue
-366.3m USD
Gross Profit
357m USD
Operating Expenses
-207.1m USD
Operating Income
149.9m USD
Other Expenses
-38.3m USD
Net Income
111.6m USD
Fundamental Scores

AMPH Profitability Score
Profitability Due Diligence

Amphastar Pharmaceuticals Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Positive 3Y Average ROIC
Healthy Gross Margin
Healthy Operating Margin
56/100
Profitability
Score

Amphastar Pharmaceuticals Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

AMPH Solvency Score
Solvency Due Diligence

Amphastar Pharmaceuticals Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Positive Net Debt
51/100
Solvency
Score

Amphastar Pharmaceuticals Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc

Wall Street analysts forecast AMPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMPH is 32.64 USD with a low forecast of 25.25 USD and a high forecast of 39.9 USD.

Lowest
Price Target
25.25 USD
1% Downside
Average
Price Target
32.64 USD
28% Upside
Highest
Price Target
39.9 USD
57% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Amphastar Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AMPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AMPH Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AMPH stock?

The intrinsic value of one AMPH stock under the Base Case scenario is 40.77 USD.

Is AMPH stock undervalued or overvalued?

Compared to the current market price of 25.44 USD, Amphastar Pharmaceuticals Inc is Undervalued by 38%.

Back to Top